risks of glp-1 GI Adverse Effects Glucagon-Like Peptide-1 Receptor Agonists Mapping the effectiveness and risks
Description
which found that OSA increased the risk of T2D (OR = 1.140, 95% CI, 1.0591.228
In contrast, whether the unstable gut-derived GLP-1 directly acts on pancreatic -cells remains controversial [58]
21 In clinical practice, pharmacists can apply this approach by counseling patients on how to monitor for GI AEs and how this correlates with appropriate dose escalation
But while semaglutide targets just GLP-1, tirzepatide targets both GLP-1 and GIPa hormone that affects how your body stores and uses fat for energy
The Benefits of GLP-1 Receptors in Cardiovascular Diseases
L.StaffordL
